Kutatási jelek – Signal Engine

• The PACIFIC Trial in Stage 3 NSCLC — NSCLC
• Radical radiotherapy use rising for treating lung cancer — Lung cancer
• Updated MARIPOSA Data Highlight Clinical Impact of Upfront Dual Inhibition in EGFR+ NSCLC — NSCLC
• Relacorilant Plus Nab-Paclitaxel Improves Outcomes in Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD — Ovarian cancer
• Study of Tislelizumab/Chemo Meets Primary End Points in Resectable NSCLC — NSCLC
• Search Continues for New Biomarkers in NSCLC — NSCLC
• ctDNA Clearance Shows Correlation With PFS Improvement in EGFR+/MET+ NSCLC — NSCLC
• How the Aging Brain Drives Tumor Progression — Glioblastoma
• Pivotal Trial Initiated for Inobrodib Combination in R/R Multiple Myeloma — Multiple myeloma
• Emiltatug Ledadotin Elicits Responses in Aggressive Adenoid Cystic Carcinoma — Adenoid cystic carcinoma
• GLP-1 Meds Not Linked to Common Thyroid Cancers, Report Finds — Thyroid cancer
• EMA Accepts Avelumab Application for Merkel Cell Carcinoma — Merkel cell carcinoma
• Case 1: Risk Stratification Models for Myelofibrosis — Myelofibrosis
• FOXD3 Is Functionally Linked to NF‑κB Signaling in KRAS G12C‑Mutant NSCLC Cells — NSCLC
• Epidemiological Assessment of Oral and Oropharyngeal Squamous Cell Carcinomas Before, During, and After the COVID-19 Pandemic, 2018–2024 — Nasopharyngeal carcinoma
• Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions — Prostate cancer
• Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1. — Ewing sarcoma
• Innovative approaches for treatment of osteosarcoma — Osteosarcoma
• Screening for Thyroid Cancer - NCBI Bookshelf — Thyroid cancer
• Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach — Ovarian cancer